Vertex Pharmaceuticals Incorporated’s $10B Crinetics Pharmaceuticals, Inc. buy adds PALSONIFY & a Phase 3 CAH asset. Click ...
Vertex Pharmaceuticals Incorporated VRTX on Monday agreed to acquire Crinetics Pharmaceuticals Inc. CRNX for $85 per share in ...
Vertex Pharmaceuticals' roughly $10 billion purchase of Crinetics Pharmaceuticals provides another near-term launch narrative with Palsonify, a treatment for acromegaly, Cantor analysts say in a ...
Creating data products is a good way to accelerate delivery, reuse data assets, reduce risks, and manage costs. Standardized ...
Global chip stocks slid overnight, putting Nasdaq 100 futures under pressure as traders watch 50-day MA support and today’s U ...
The British energy major said its gas-trading division is expected to report significantly higher results than the first quarter, and it raised its second-quarter integrated gas unit production ...
DOOM: The Dark Ages | Revelations — id Software's first and only paid expansion for its 2025 shooter — goes live today, July 7, across PC (Steam), PlayStation 5, and Xbox Series X|S, unlocking ...
Casgevy is now approved in the U.S. for children with sickle cell as young as 2, becoming the first gene-editing therapy for ...
The roller-coaster ride for AI stocks snapped back down and dragged Wall Street lower. The S&P 500 fell 0.4% Tuesday, even ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results